On
#India's National Cancer Awareness Day,
@FDAOncology's Srivastava, FDA India Office's Smith & other FDA officials were honored to join the ICMR-PGIMER Workshop in Chandigarh focusing on the regulatory aspects of Phase 1 Clinical trials, a pivotal component in new drug R&D.